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Leishmaniasis has been documented in several countries, 
with an estimated prevalence of 12 million people and 
an incidence at around 400,000 new cases per year. 
Leishmaniasis in the New World is one the major endemic 
diseases in Brazil and Latin America. Objective: The aim of 
this study was to add to the current knowdlegde on mucosal 
leishmaniasis, bringing the experience of the Imunology 
and Otolaryngology Departments in the Professor Edgar 
Santos University Hospital of the Federal University of Bahia. 
Conclusion: Cutaneous leishmaniasis is the most common 
form of New World Leishmaniasis; mucosal legions may 
occur simultaneously or after years of disease. Mucosal 
leishmaniasis is caused mainly by L. braziliensis braziliensis; 
although the nasal mucosa is the most affected area, lesions 
may be found on the lips, mouth, pharynx and larynx. In 
addition to parasite-related factors, the host immune response 
may be involved in the pathogenicity of lesions in mucosal 
leishmaniasis.
Keywords: granulomatous disease, leishmaniasis, mucosal 
leishmaniasis.
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INTRODUCTION
Studies on leishmaniasis in the Southwestern portion 
of the state of Bahia started in the 1970s. A leishmaniasis 
unit was set up in the Três Braços region, in the town of 
Wenceslau Guimarães.1 Most of the cases of leishmaniasis 
diagnosed in 20 municipalities are referred to the health 
unit that was built in Corte de Pedra, a village located 30 
km from the Três Braços region. Currently, about 500 cases 
of cutaneous leishmaniasis and 10 to 20 cases of mucosal 
leishmaniasis are seen at this health unit each year. In this 
paper we reviewed the epidemiology and clinical findin-
gs of mucosal leishmaniasis, based on the experience of 
the Immunology and Otorhinolaryngological Units of the 
Professor Edgar Santos University Hospital, which is part 
of the Federal University of Bahia.
EPIDEMIOLOGY AND TAXONOMY
The term leishmaniasis refers to the infection of 
vertebrate hosts by protozoans of the genus Leishmania, 
which belongs to the order Kinetoplastida. Similar to other 
trypanosomes, they typically present extranuclear DNA in 
their cytoplasm within a mitochondrial organelle called the 
kinetoplast. This genus features two developmental forms 
during its biological cycle in host organisms, as follows: 
amastigotes, obligatory intracellular parasite in vertebra-
tes, and promastigotes, which develop in the intestine of 
invertebrate vectors or in axenic cultures.
Leishmanioses are primarily zoonotic infections 
that affect species other than Man, which may become 
involved secondarily; transmission between humans may 
occur and may even predominate or become exclusive. 
Transmission is usually due to the bites of sand flies in 
the genuses Phlebotomus and Lutzomya, depending on 
geography.
American tegumentary leishmaniasis (ATL) is among 
the major endemic diseases in Brazil and Latin América.2 
The growing number of new cases is evident, even when 
taking into account failures in compulsory reporting. A 
calculation has suggested that the worldwide prevalence of 
leishmaniasis is 12 million people in 80 countries; estimates 
suggest that there are 400,000 new cases each year.
Leishmaniases are widely distributed and have been 
documented in Africa, Europe, Asia and America.3 In the 
Old World the main causal agents of this disease are L. 
Tropica, L. major and L. aethiopica, which cause tegumen-
tary leishmaniasis, and L. donovani and L. infantum, which 
cause visceral leishmaniasis. In the Americas, L. chagasi is 
associated with visceral leishmaniasis; various leishmania 
species are able to produce tegumentary leishmaniasis, 
such as: L. braziliensis (Lvb), L. amazonensis, L. guianen-
sis, L. pananmensis and L. mexicana. The characterization 
of leishmania species, which was initially done based on 
the behavior of the parasite in the vector, today is based 
on biochemical, immunological and molecular biological 
techniques. These include isoenzyme analysis, monoclonal 
antibody reactivity and kinetoplast DNA analysis.4 
Mucosal leishmaniasis is a form of tegumentary 
leishmaniasis that is associated with L. braziliensis, L. pa-
namensis and less frequently with L. amazonensis.
Prior studies have brought attention to the risk 
factors for developing mucosal leishmaniasis, namely the 
presence of lesions above the pelvic girdle, large cutaneous 
ulcers and inadequately treated cutaneous leishmaniasis.5 
Isolated series have also demonstrated a high frequency of 
mucosal disease in disseminated cutaneous leishmaniasis 
patients.6 Specifically in such cases, there are multiple 
lesions both below and above the pelvic girdle, including 
significant involvement of the face.6 
CLINICAL FINDINGS
The frequency of tegumentary leishmaniasis is hi-
gher compared to visceral leishmaniasis. Classically it is 
characterized by well-defined ulcers with elevated borders 
(Figure 1). In ATL caused by L. braziliensis, recent studies 
have shown that lymph nodes close to the parasite inocu-
lation site are enlarged days or weeks before the lesions 
appear. Lymph node enlargement is painless or mildly 
painful and is commonly documented at over 5 cm in dia-
meter. As most of the ulcers caused by L. braziliensis are 
located in the lower limbs, most of these lymph nodes are 
found in the groin, the crural region, and less frequently 
in the popliteal region. In the upper limbs epitrochlear 
and axillary lymph nodes may be involved. Lymph node 
enlargement regresses after a few weeks, although it may 
still be found in patients with cutaneous ulcers lasting 
over 2 months.
In L. brasiliensis transmission regions around 3% 
of cutaneous leishmaniasis patients will concomitantly 
or after disease remission develop a mucosal form of the 
disease, known as espundia. Two other clinical forms of 
tegumentary leishmaniasis are well known besides the 
classical cutaneous and the mucosal forms: disseminated 
cutaneous leishmaniasis and diffuse cutaneous leishma-
niasis. Both forms present multiple lesions, but there are 
clear clinical, histological, pathological and immunolo-
gical differences in these conditions.8 In Brazil diffuse 
cutaneous leishmaniasis is caused by L. amazonensis and 
presents as nodules. The intradermal test using leishma-
nia antigens is negative as there is no cellular immune 
response to parasites. Histopathology is characterized by 
a macrophage infiltrate full of leishmania.6 Disseminated 
cutaneous leishmaniasis presents acneiform lesions that 
eventually may become ulcers. Histopathology reveals an 
eosinophilic and/or lymphoplasmocytic infiltrate; parasi-
tes may or may not be found in the lesion. The immune 
response is variable, but is preserved in most cases.6 In 
diffuse cutaneous leishmaniasis the nasal mucosa is not 
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involved; in the disseminated form, involvement of the 
nose is frequent.6 
The reason why leishmaniasis patients develop 
mucosal involvement is not fully clear. The association be-
tween L. braziliensis and this form of the disease suggests 
that parasite-related factors, as well as host conditions, may 
play a relevant role in mucosal involvement. It is currently 
accepted that clinically evident leishmaniasis depends 
on parasite factors, host resistance and the level of the 
immunological response.9 Progression of the disease in 
Man, from cutaneous to nose lesions, appears to take place 
through the lymphatic system, blood vessels (metastases) 
and rarely by direct contact between the mucosa and the 
cutaneous lesion, such as in the case of a mother with a 
cutaneous lesion close to the nipples whose newborn de-
velops a mucosal lesion in the mouth.  It is also known that 
vessels in the anterior nasal septum (Kiesselbach’s zone) 
provide good conditions for the development of amasti-
gotes. According to certain authors, lower temperatures 
in the nose and the passageways for food make it easier 
for parasites to install themselves in these regions.10 The 
association between lower temperatures and leishmania 
parasites may in part be explained by in vitro experiments 
showing that macrophages cultivated at 29°C are less able 
to destroy parasites compared to macrophages cultivated 
at 33°C.10 
In 1936 Barbosa noted the importance of mucosal 
leishmaniasis based on case studies in the otorhinolaryn-
gology unit of the Santa Casa de Misericordia Hospital in 
Sao Paulo.11 The nose mucosa is one of the preferred sites 
for L. braziliensis to cause lesions.  Although the mouth, 
the pharynx and the larynx may be involved, the favorite 
sites for manifestations of this disease are the cartilaginous 
nasal septum and anterior portions of the nasal fossae such 
as the vestibule, the lower turbinates and the floor of the 
nose (Figure 2). Mucosal involvement is usually seconda-
ry to cutaneous lesions, although there are cases where 
the mucosa is the primary site. In over 90% of mucosal 
lesions - whether primary or secondary - the nose is the 
only site with disease.8 
Figure 1. Tegumentary lesion in the right lower limb, showing a well-
defined ulcer with elevated borders.
Figure 2. Endoscopy of the right nasal fossa showing perforation of 
the anterior nasal septum (*) and a granulomatous lesion involving the 
mucosa in the anterior nasal septum, the tip of the lower turbinate and 
the floor of the nasal fossa (CI = lower turbinate; Se = septum).
Both cutaneous and mucosal leishmaniasis predo-
minate in male adults,5,12 although recently more children 
of both sexes are being documented with the disease.13 
Certain patients may present nasal mucosa invol-
vement in the absence of cutaneous disease. 12 Although 
data on the penetration site of leishmania in these cases 
may be absent, and subclinical forms of the disease may 
not be demonstrated, it is possible that parasites may 
have entered at the limen nasi - the cutaneous-mucosal 
transition of the nose - in patients with mucosal disease 
and no cutaneous involvement.
Studies undertaken in the Três Braços (state of 
Bahia) endemic region have shown that mucosal leishma-
niasis may present up to 264 days following a cutaneous 
lesion. Only 7% of patients, however, developed muco-
sal disease after over 10 years after the presentation of a 
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cutaneous lesion. 8 
The earliest symptoms and signs of mucosal leish-
maniasis are nose block, nose bleeding and granulomas 
in the anterior nasal septum. 8 Initially, the anterior septal 
mucosa is warm and swollen and nodules eventually 
develop. During this phase patients present rhinorrhea, 
eventually presenting septal perforation after a few days or 
months. The skin of the nose may be thickened, swollen 
and hyperemic, which increases the volume of the nasal 
pyramid. As the disease progresses, patients begin to pre-
sent a leishmaniotic facies known as the “tapir nose”, which 
results from edema of the lining and supporting structures 
of the nose. Eventually, aggression of tissues may involve 
the whole nose, the upper lip, the palate and the pharynx, 
resulting in severe deformity (Figure 3), mutilation, and 
feeding, breathing and phonation difficulties. 
The differential diagnosis includes other granulo-
matous diseases such as blastomycosis (Paracoccidiose 
braziliensis), leprosy and tuberculosis, all of which may 
also present in the anterior nasal septum. The connective 
tissue reaction in L. braziliensis infection is significant. 
Scarring characterized by whitish cords during the healing 
of mucosal lesions separates leishmaniasis from other 
anterior nasal granulomas.
INVOLVEMENT OF THE MOUTH, PHARYNX AND 
LARYNX IN MUCOSAL LEISHMANIASIS
The pharynx is the second preferred site for mu-
cosal lesions caused by Leishmania braziliensis. Similar 
to the nose, a mucosal lesion in the pharynx takes on a 
melon-like quality; however the edema is significantly 
increased, particularly in the uvula, the tonsillar pillars 
and the posterior wall of the pharynx. Granulation tissue, 
that permeates the mucosal findings, is not extensive in 
this phase. The next phase witnesses the increase of gra-
nulation tissue, which significantly destroys tissue; it also 
involves the lymphoid tissue in Waldeyer’s lymphatic ring 
in the tonsillar region. Areas with a tenuous fibrin layer 
mix with granulation tissues, with its vegetating appea-
rance (Figure 4). Abundant fibrous tissue may be found, 
forming true whitish cords that deform completely the 
anatomical structures of the palate and posterior pharynx 
due to the intense tissue aggression during the specific 
post-treatment healing process; this process results in sig-
nificant stenosis in the transition between the oropharynx 
and the rhinopharynx.14 
The laryngeal mucosa is the third preferred site 
for mucosal involvement in leishmaniasis. Similar to the 
pharynx, mucosal lesions present the same type of fine 
granulous tissue. With increased inflammation, vegeta-
ting granulous tissue covered with a tenuous fibrin layer 
involves the mucosa, the epiglottis, and extends to the 
mucosa of the laryngeal vestibule and the vocal folds. 
During this phase dysphonia - characterized by a muffled 
voice - is always present, which brings attention to the 
vocal folds.14 
Involvement of the cartilage in the epiglottis and 
the arytenoids may occur as in the cartilaginous septum 
to a greater or lesser degree, resulting in perichondritis, 
which makes swallowing very painful. Painful dysphagia 
in varying degrees hinders normal feeding, leading to 
malnutrition and even cachexia. Cartilaginous deformity 
is significantly evident in post-treatment healing; fibrous 
tissue is whitish and completely changes the anatomy, 
resulting in permanent residual dysphonia.14 
The ears are usually not involved in mucosal 
leishmaniasis. Mucosal involvement of the rhinopharynx, 
however, affects the pharyngeal orifice of the Eustachian 
tube. In these cases otitis media with effusion may be 
present (chronic secreting otitis media); this finding was 
Figure 3. Deformity of the external structure of the nasal pyramid in a 
patient with mucosal leishmaniasis.
Figure 4. Vegetating granulation tissue involving the soft palate and 
the uvula, covered with a tenuous fibrin layer.
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present in three cases in our series. 15 The feeling of a 
blocked ear, tinnitus and dysacusis are the complaints 
found in such cases.
Mucosal leishmaniasis may involve the mucosa of 
the lips and the gingival border. This is a less common 
presentation of the disease. Under these conditions a di-
fferential diagnosis should be made with blastomycosis, 
particularly due to involvement of the gingival mucosa, 
a frequent finding in Paracoccidioidis braziliensis infec-
tion.
FINAL COMMENTS
Mucosal leishmaniasis is a form of tegumentary 
leishmaniasis that is associated with L. braziliensis, L. 
panamensis and less frequently with L. amazonensis. The 
frequency of this disease varies in epidemiological and 
clinical studies. Although the nose mucosa is the preferred 
site for the mucosal form of leishmaniasis, other sites may 
include the lips, the mouth, the pharynx and the larynx. 
This conditions results in high morbidity. The middle ear 
may be involved in more advanced forms of mucosal 
leishmaniasis (chronic otitis media with effusion) due to 
granulomatous tissue in the rhinopharynx, which alters the 
function of the Eustachian tube. The differential diagnosis 
of mucosal leishmaniasis includes other granulomatous di-
seases such as blastomycosis (Paracoccidiose braziliensis), 
leprosy and tuberculosis, all of which may also present in 
the anterior nasal septum.
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